Publicacions (21) Publicacions de ANTONIO RUBIO DEL CAMPO

2023

  1. A Tailored Strategy to Crosslink the Aspartate Transcarbamoylase Domain of the Multienzymatic Protein CAD

    Molecules, Vol. 28, Núm. 2

  2. Beyond genetics: Deciphering the impact of missense variants in CAD deficiency

    Journal of Inherited Metabolic Disease, Vol. 46, Núm. 6, pp. 1170-1185

  3. C-2 Thiophenyl Tryptophan Trimers Inhibit Cellular Entry of SARS-CoV-2 through Interaction with the Viral Spike (S) Protein

    Journal of Medicinal Chemistry, Vol. 66, Núm. 15, pp. 10432-10457

2022

  1. Infant Gut Microbial Metagenome Mining of α-l-Fucosidases with Activity on Fucosylated Human Milk Oligosaccharides and Glycoconjugates

    Microbiology spectrum, Vol. 10, Núm. 4, pp. e0177522

  2. Replication of Human Norovirus in Mice after Antibiotic-Mediated Intestinal Bacteria Depletion

    International Journal of Molecular Sciences, Vol. 23, Núm. 18

2021

  1. Infant gut microbiota modulation by human milk disaccharides in humanized microbiome mice

    Gut Microbes, Vol. 13, Núm. 1, pp. 1-20

  2. Infant-gut associated Bifidobacterium dentium strains utilize the galactose moiety and release lacto-N-triose from the human milk oligosaccharides lacto-N-tetraose and lacto-N-neotetraose

    Scientific Reports, Vol. 11, Núm. 1

  3. Interaction of intestinal bacteria with human rotavirus during infection in children

    International Journal of Molecular Sciences, Vol. 22, Núm. 3, pp. 1-12

  4. Microbiota depletion promotes human rotavirus replication in an adult mouse model

    Biomedicines, Vol. 9, Núm. 7

2020

  1. Human milk and mucosa-associated disaccharides impact on cultured infant fecal microbiota

    Scientific Reports, Vol. 10, Núm. 1

  2. Sero-epidemiological study of the rotavirus VP8* protein from different P genotypes in Valencia, Spain

    Scientific Reports, Vol. 10, Núm. 1

2014

  1. Noroviral P-particles as an in vitro model to assess the interactions of noroviruses with probiotics

    PLoS ONE, Vol. 9, Núm. 2

2012

  1. Carbonic anhydrase IX as a specific biomarker for clear cell renal cell carcinoma: Comparative study of Western blot and immunohistochemistry and implications for diagnosis

    Scandinavian Journal of Urology and Nephrology, Vol. 46, Núm. 5, pp. 358-364

  2. GSTT1, GSTM1, and CYP1B1 gene polymorphisms and susceptibility to sporadic renal cell cancer

    Urologic Oncology: Seminars and Original Investigations, Vol. 30, Núm. 6, pp. 864-870

  3. Lactobacillus casei ferments the N-Acetylglucosamine moiety of fucosyl-α-1,3-N-acetylglucosamine and excretes L-fucose

    Applied and Environmental Microbiology, Vol. 78, Núm. 13, pp. 4613-4619

  4. Metabolic engineering of Lactobacillus casei for production of UDP-N-acetylglucosamine

    Biotechnology and Bioengineering, Vol. 109, Núm. 7, pp. 1704-1712

  5. Regulatory insights into the production of UDP-N-acetylglucosamine by lactobacillus casei

    Bioengineered, Vol. 3, Núm. 6, pp. 339-342

2011

  1. Polymorphic deletions of the GSTT1 and GSTM1 genes and susceptibility to bladder cancer

    BJU International, Vol. 107, Núm. 11, pp. 1825-1832

2008

  1. Implications of mismatch repair genes hMLH1 and hMSH2 in patients with sporadic renal cell carcinoma

    BJU International, Vol. 102, Núm. 4, pp. 504-509

  2. Implications of p53 gene mutations on patient survival in transitional cell carcinoma of the bladder: A long-term study

    Urologic Oncology: Seminars and Original Investigations, Vol. 26, Núm. 6, pp. 620-626